The AJMC® Migraine compendium is a comprehensive resource for clinical news and expert insights for the recurring type of headache, which is accompanied by side effects.
April 20th 2023
This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Express Scripts Launching Value-Based Migraine Program
October 17th 2018Starting April 1, 2019, Express Scripts will offer its SafeGuardRx Migraine Care Value program, which will help patients achieve better outcomes with preventive therapies and offer a value-based design for plan sponsors.
Read More
Inhaler Effective for Treating Migraine Attacks, According to Pilot Study
October 12th 2018In some instances, migraine can be treated without medicine, meaning some patients with migraine can cut down on their medication use, according to a new study that demonstrated efficacy with an inhaler that slightly changes the body’s own molecules.
Read More
Regular Exercise May Reduce Frequency of Migraine, Study Finds
September 29th 2018Researchers recently investigated what role exercise plays in migraine prevention and found that although exercise can trigger migraine attacks, regular exercise may have prophylactic effects on migraine frequency.
Read More
Survey: Women Lack Confidence in Insurers, Employers to Meet the Needs of People With Migraine
September 17th 2018The survey of more than 340 women revealed an overwhelming belief that people with migraine are dismissed as exaggerating their symptoms and that employers don't understand the burden of migraine on their employees.
Read More
Prolonged Aura in Migraine Is Frequent, Similar to Other Auras
September 14th 2018A recent study has found that prolonged auras are common and are phenotypically similar to other auras. Based on the observed duration of aura symptoms, the researchers suggest reconsidering the use of the term “prolonged aura."
Read More
Prevalence of Acute Medication Use, Overuse, and Discontinuation Among Patients With Migraine
September 11th 2018Two studies presented at the PAINWeek conference in Las Vegas, Nevada, took a look into the prevalence of acute medication use and overuse among migraineurs, as well as rates of medication discontinuation due to lack of efficacy or side effects.
Read More
electroCore Unveils New Version of Noninvasive Vagus Nerve Stimulator for Migraine Pain
September 8th 2018GammaCore Sapphire, the newest version of gammaCore—a noninvasive vagus nerve stimulator—is now available in the United States to treat patients with migraine and episodic cluster headache.
Read More